Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma-Reference-Cited by-同舟云学术

Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma

Published:2022-02-01 Issue:3 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Seebauer Caroline T.,Graus Matthew S.,Lan Huang ,McCann Alex,Wylie-Sears Jill,Fontaine Frank,Karnezis Tara,Zurakowski David^ORCID,Staffa Steven J.^ORCID,Meunier Frédéric,Mulliken John B.,Bischoff Joyce^ORCID,Francois Mathias^ORCID

Funder

National Institutes of Health

Deutsche Forschungsgemeinschaft (DFG) grant

National Health and Medical Research Council

National Health and Medical Research Council Career Development Fellows

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/151109/files/pdf

Reference76 articles.

1. Infantile haemangioma

2. Incidence and treatment of infantile haemangioma in preterm infants

3. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies

4. Diagnosis and Management of Infantile Hemangioma

5. Infantile Hemangiomas in the Head and Neck Region

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the mechanisms of angiogenesis in infantile hemangioma;Biomedicine & Pharmacotherapy;2024-09

2. Once-a-Day Administration of R(+) Propranolol Is Sufficient to Block Vasculogenesis in a Xenograft Model of Infantile Hemangioma;Journal of Vascular Anomalies;2024-08-07

3. The negative chronotropic effects of (±)-propranolol and (±)- 4-NO 2 -propranolol in the rat isolated right atrium are due to blockade of the 6-nitrodopamine receptor;2024-07-29

4. R(+) Propranolol decreases lipid accumulation in hemangioma-derived stem cells;2024-07-02

5. Cell Fate Regulation During the Development of Infantile Hemangioma;Journal of Investigative Dermatology;2024-07